ICON plc (ICLR)
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
📈 **POSITIVE** • High confidence analysis (82%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business